Patents Assigned to Axellia Pharmaceuticals ApS
  • Process for purifying lipopeptides
    Publication number: 20100228006
    Abstract: The present invention relates to a process for purifying lipopeptides. More particular, the invention provides an improved method for purifying daptomycin.
    Type: Application
    Filed: February 19, 2010
    Publication date: September 9, 2010
    Applicant: AXELLIA PHARMACEUTICALS APS
    Inventors: Martin Mansson, Eli Karin Dale, Sissel Hauge, Carsten Overballe-Petersen, Kjersti Aastorp Hirth, Dennis Brian Hansen
  • Purification of mupirocin
    Patent number: 7619102
    Abstract: A method for purification of the antibiotic mupirocin (pseudomonic acid A) which comprises: a) Causing or allowing precipitation of mupirocin from an aqueous solution thereof; b) Recovering the precipitate; c) Dissolving the recovered precipitate in an organic solvent.
    Type: Grant
    Filed: February 21, 2006
    Date of Patent: November 17, 2009
    Assignee: Axellia Pharmaceuticals ApS
    Inventors: Marc Antonius Theodorus Bisschops, Tiemen Geert Pieter Reijns, Anita Mathiesen, Lene Aassveen
  • PREPARATION AND PURIFICATION OF MUPIROCIN CALCIUM
    Publication number: 20090240071
    Abstract: The present invention relates to methods for the preparation and purification of mupirocin calcium. The process comprises adsorbing mupirocin to a hydrophobic adsorbent resin, exposing the bound mupirocin to a calcium-containing solution, washing impurities from the resin and eluting purified mupirocin calcium from the resin.
    Type: Application
    Filed: August 29, 2007
    Publication date: September 24, 2009
    Applicant: Axellia Pharmaceuticals ApS
    Inventor: Lene Aassveen